{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:12Z","timestamp":1791209292276,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T00:00:00Z","timestamp":1334620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00535-012-0586-z","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T05:08:01Z","timestamp":1334552881000},"page":"498-503","source":"Crossref","is-referenced-by-count":43,"title":["Autoimmune hepatitis: a review"],"prefix":"10.1007","volume":"47","author":[{"given":"Andrea A.","family":"Gossard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"issue":"1","key":"586_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139(1):58\u201372 e4.","journal-title":"Gastroenterology"},{"issue":"1","key":"586_CR2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354(1):54\u201366.","journal-title":"N Engl J Med"},{"issue":"6","key":"586_CR3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bjornsson","year":"2010","unstructured":"Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51(6):2040\u20138.","journal-title":"Hepatology"},{"issue":"5","key":"586_CR4","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/hep.24513","volume":"54","author":"K Sugimoto","year":"2011","unstructured":"Sugimoto K, Ito T, Yamamoto N, Shiraki K. Seven cases of autoimmune hepatitis that developed after drug-induced liver injury. Hepatology. 2011;54(5):1892\u20133.","journal-title":"Hepatology"},{"issue":"6","key":"586_CR5","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","volume":"52","author":"C Efe","year":"2010","unstructured":"Efe C, Purnak T, Ozaslan E, Wahlin S. Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents. Hepatology. 2010;52(6):2246\u20137.","journal-title":"Hepatology"},{"issue":"8","key":"586_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/MCG.0b013e31818c8801","volume":"43","author":"J Ramakrishna","year":"2009","unstructured":"Ramakrishna J, Johnson AR, Banner BF. Long-term minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol. 2009;43(8):787\u201390.","journal-title":"J Clin Gastroenterol"},{"issue":"7","key":"586_CR7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1445-5994.2009.01971.x","volume":"39","author":"J Healy","year":"2009","unstructured":"Healy J, Alexander B, Eapen C, Roberts-Thomson IC. Minocycline-induced autoimmune hepatitis. Intern Med J. 2009;39(7):487\u20138.","journal-title":"Intern Med J"},{"issue":"11","key":"586_CR8","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","volume":"17","author":"K Subramaniam","year":"2011","unstructured":"Subramaniam K, Chitturi S, Brown M, Pavli P. Infliximab-induced autoimmune hepatitis in Crohn\u2019s disease treated with budesonide and mycophenolate. Inflamm Bowel Dis. 2011;17(11):E149\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"586_CR9","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2009.02.029","volume":"63","author":"C Goujon","year":"2010","unstructured":"Goujon C, Dahel K, Berard F, Guillot I, Gunera-Saad N, Nicolas JF. Autoimmune hepatitis in two psoriasis patients treated with infliximab. J Am Acad Dermatol. 2010;63(2):e43\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"586_CR10","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/MCG.0b013e3181a745e7","volume":"44","author":"T Adar","year":"2010","unstructured":"Adar T, Mizrahi M, Pappo O, Scheiman-Elazary A, Shibolet O. Adalimumab-induced autoimmune hepatitis. J Clin Gastroenterol. 2010;44(1):e20\u20132.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"586_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.crohns.2010.12.007","volume":"5","author":"A Doyle","year":"2011","unstructured":"Doyle A, Forbes G, Kontorinis N. Autoimmune hepatitis during infliximab therapy for Crohn\u2019s disease: a case report. J Crohns Colitis. 2011;5(3):253\u20135.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"586_CR12","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","volume":"56","author":"DA Goldfeld","year":"2011","unstructured":"Goldfeld DA, Verna EC, Lefkowitch J, Swaminath A. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn\u2019s disease: the index case. Dig Dis Sci. 2011;56(11):3386\u20138.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"586_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","volume":"42","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42(1):53\u201362.","journal-title":"Hepatology"},{"issue":"10","key":"586_CR14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2010.01.002","volume":"42","author":"KR Radhakrishnan","year":"2010","unstructured":"Radhakrishnan KR, Alkhouri N, Worley S, Arrigain S, Hupertz V, Kay M, et al. Autoimmune hepatitis in children\u2014impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis. 2010;42(10):724\u20138.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"586_CR15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrgastro.2011.69","volume":"8","author":"G Mieli-Vergani","year":"2011","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol. 2011;8(6):320\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"586_CR16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MCG.0b013e3181d7b1ac","volume":"44","author":"C Efe","year":"2010","unstructured":"Efe C, Purnak T, Ozaslan E. Concurrent autoimmune thyroid diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44(9):660\u20131.","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"586_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.dld.2010.02.006","volume":"42","author":"F Mirzaagha","year":"2010","unstructured":"Mirzaagha F, Azali SH, Islami F, Zamani F, Khalilipour E, Khatibian M, et al. Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis. 2010;42(9):620\u20133.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"586_CR18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","volume":"44","author":"A Teufel","year":"2010","unstructured":"Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Worns M, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44(3):208\u201313.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"586_CR19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0b013e31802dbdfc","volume":"42","author":"PL Bittencourt","year":"2008","unstructured":"Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, et al. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol. 2008;42(3):300\u20135.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"586_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dld.2010.09.011","volume":"43","author":"A Colecchia","year":"2011","unstructured":"Colecchia A, Di Biase AR, Scaioli E, Festi D. Coeliac disease and autoimmune hepatitis: gluten-free diet can influence liver disease outcome. Dig Liver Dis. 2011;43(3):247.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"586_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11593150-000000000-00000","volume":"14","author":"F Panetta","year":"2012","unstructured":"Panetta F, Nobili V, Sartorelli MR, Papa RE, Ferretti F, Alterio A, et al. Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management. Paediatr Drugs. 2012;14(1):35\u201341.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"586_CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOG.0b013e3283457ce0","volume":"27","author":"MJ Mayo","year":"2011","unstructured":"Mayo MJ. Management of autoimmune hepatitis. Curr Opin Gastroenterol. 2011;27(3):224\u201330.","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"586_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","volume":"29","author":"G Mieli-Vergani","year":"2009","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis. 2009;29(3):297\u2013306.","journal-title":"Semin Liver Dis"},{"issue":"7","key":"586_CR24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","volume":"9","author":"A Bonder","year":"2011","unstructured":"Bonder A, Retana A, Winston DM, Leung J, Kaplan MM. Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2011;9(7):609\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"586_CR25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54(2):374\u201385.","journal-title":"J Hepatol"},{"issue":"1","key":"586_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0961203310378673","volume":"20","author":"LA Gonzalez","year":"2011","unstructured":"Gonzalez LA, Orrego M, Ramirez LA, Vasquez G. Primary biliary cirrhosis\/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: a case report and review of the literature. Lupus. 2011;20(1):108\u201311.","journal-title":"Lupus"},{"issue":"8","key":"586_CR27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cgh.2010.04.007","volume":"8","author":"C Efe","year":"2010","unstructured":"Efe C, Purnak T, Ozaslan E. The diagnostic criteria for patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8(8):734.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"586_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","volume":"105","author":"M Neuhauser","year":"2010","unstructured":"Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol. 2010;105(2):345\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"586_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","volume":"43","author":"S Luth","year":"2009","unstructured":"Luth S, Kanzler S, Frenzel C, Kasper HU, Dienes HP, Schramm C, et al. Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol. 2009;43(1):75\u201380.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"586_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","volume":"28","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther. 2008;28(2):209\u201320.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"586_CR31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365520903555861","volume":"45","author":"M Werner","year":"2010","unstructured":"Werner M, Wallerstedt S, Lindgren S, Almer S, Bjornsson E, Bergquist A, et al. Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response. Scand J Gastroenterol. 2010;45(4):457\u201367.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"586_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MM Lamers","year":"2010","unstructured":"Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol. 2010;53(1):191\u20138.","journal-title":"J Hepatol"},{"issue":"1","key":"586_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","volume":"51","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol. 2009;51(1):161\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"586_CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2011.04690.x","volume":"34","author":"Q Wang","year":"2011","unstructured":"Wang Q, Qiu D, Ma X. Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients. Aliment Pharmacol Ther. 2011;34(1):107\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"586_CR35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0676.2003.00810.x","volume":"23","author":"AJ Czaja","year":"2003","unstructured":"Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int. 2003;23(2):116\u201323.","journal-title":"Liver Int"},{"issue":"9","key":"586_CR36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1345\/aph.1Q244","volume":"45","author":"KR Snider","year":"2011","unstructured":"Snider KR, Potter TG. Budesonide for the treatment of autoimmune hepatitis. Ann Pharmacother. 2011;45(9):1144\u201350.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"586_CR37","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010;139(4):1198\u2013206.","journal-title":"Gastroenterology"},{"issue":"12","key":"586_CR38","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","volume":"103","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C, et al. Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol. 2008;103(12):3063\u201370.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"586_CR39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","volume":"6","author":"JT Hlivko","year":"2008","unstructured":"Hlivko JT, Shiffman ML, Stravitz RT, Luketic VA, Sanyal AJ, Fuchs M, et al. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2008;6(9):1036\u201340.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"586_CR40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/egh.11.45","volume":"5","author":"HI Fallatah","year":"2011","unstructured":"Fallatah HI, Akbar HO. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy. Expert Rev Gastroenterol Hepatol. 2011;5(4):517\u201322.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"586_CR41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jhep.2011.01.012","volume":"55","author":"C Schramm","year":"2011","unstructured":"Schramm C, Lohse AW. Role of mycophenolate mofetil in the treatment of autoimmune hepatitis. J Hepatol. 2011;55(3):510\u20131.","journal-title":"J Hepatol"},{"issue":"3","key":"586_CR42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","volume":"55","author":"K Zachou","year":"2011","unstructured":"Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol. 2011;55(3):636\u201346.","journal-title":"J Hepatol"},{"issue":"3","key":"586_CR43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","volume":"34","author":"AM Baven-Pronk","year":"2011","unstructured":"Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, et al. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther. 2011;34(3):335\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"586_CR44","doi-asserted-by":"crossref","unstructured":"Garcia-Buey L, Moreno-Otero R. Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther. 2011;34(6):682\u20134 (author reply 4\u20135).","DOI":"10.1111\/j.1365-2036.2011.04763.x"},{"issue":"10","key":"586_CR45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","volume":"24","author":"K Sharzehi","year":"2010","unstructured":"Sharzehi K, Huang MA, Schreibman IR, Brown KA. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol. 2010;24(10):588\u201392.","journal-title":"Can J Gastroenterol"},{"issue":"6","key":"586_CR46","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193\u2013213.","journal-title":"Hepatology"},{"issue":"2","key":"586_CR47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36(2):479\u201397.","journal-title":"Hepatology"},{"issue":"1","key":"586_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00404-010-1540-z","volume":"284","author":"N Aggarwal","year":"2011","unstructured":"Aggarwal N, Chopra S, Suri V, Sikka P, Dhiman RK, Chawla Y. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet. 2011;284(1):19\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"586_CR49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","volume":"101","author":"C Schramm","year":"2006","unstructured":"Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006;101(3):556\u201360.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"586_CR50","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1023\/A:1005638500236","volume":"45","author":"SZ Park","year":"2000","unstructured":"Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci. 2000;45(10):1944\u20138.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"586_CR51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0029-1233531","volume":"29","author":"D Tripathi","year":"2009","unstructured":"Tripathi D, Neuberger J. Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease. Semin Liver Dis. 2009;29(3):286\u201396.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"586_CR52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/lt.22244","volume":"17","author":"SR Martin","year":"2011","unstructured":"Martin SR, Alvarez F, Anand R, Song C, Yin W. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl. 2011;17(4):393\u2013401.","journal-title":"Liver Transpl"},{"issue":"4","key":"586_CR53","first-page":"461","volume":"16","author":"C Schramm","year":"2010","unstructured":"Schramm C, Bubenheim M, Adam R, Karam V, Buckels J, O\u2019Grady JG, et al. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl. 2010;16(4):461\u20139.","journal-title":"Liver Transpl"},{"issue":"3","key":"586_CR54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPG.0b013e3181bf0ef7","volume":"50","author":"PF Chai","year":"2010","unstructured":"Chai PF, Lee WS, Brown RM, McPartland JL, Foster K, McKiernan PJ, et al. Childhood autoimmune liver disease: indications and outcome of liver transplantation. J Pediatr Gastroenterol Nutr. 2010;50(3):295\u2013302.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"586_CR55","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","volume":"15","author":"JC Duclos-Vallee","year":"2009","unstructured":"Duclos-Vallee JC, Sebagh M. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. Liver Transpl. 2009;15(Suppl 2):S25\u201334.","journal-title":"Liver Transpl"},{"issue":"9","key":"586_CR56","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","volume":"14","author":"J Campsen","year":"2008","unstructured":"Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, et al. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl. 2008;14(9):1281\u20136.","journal-title":"Liver Transpl"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0586-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-012-0586-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-012-0586-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:02:29Z","timestamp":1642032149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-012-0586-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,17]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1007\/s00535-012-0586-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,17]]}}}